Live symbol workspace

SUNPHARMA market intelligence

Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.

Status Chart ready

{# Only render the live technical grid when the AI analysis carries real, non-placeholder data. Sentinel payloads (data_status error/collecting, current_price 0) are handled by the Asset Intelligence Dossier below, which degrades to a calm branded empty state instead of "0%" widgets. #}

Asset Intelligence Dossier

AI dossier is still gathering data for this asset

We publish verified AI sentiment once enough provider calls have been scored against real market moves for this symbol.

See our verified AI accuracy leaderboard →

Insider Trading

Refreshing insider trades from FinViz…

Technical Observations

Refreshing technical observations from FinViz...

SUNPHARMA News Intelligence (2 articles)

AI-curated news influencing SUNPHARMA price, sentiment, and trend

Explore All SUNPHARMA News with AI Analysis

Economy

1 month, 1 week ago

Sun Pharma Explores Funding Mix for $12 Billion Organon Deal

Global lenders to Sun Pharmaceutical Industries Ltd. are weighing multiple financing options for its proposed $12 billion acquisition of New …

Impact on SUNPHARMA: The potential acquisition could lead to a short-term increase in Sun Pharma's …

Sun Pharma's proposed $12 billion acquisition of Organon & Co. is exploring funding options, which … Medium (60%)

View full analysis →

Bloomberg 60% confidence

Stocks

1 month, 3 weeks ago

Indian drugmaker Sun Pharma to buy U.S. firm Organon in $11.75 billion deal

To fuel its global ambitions, Sun Pharmaceutical Industries plans to acquire New Jersey-based Organon & Co in an all-cash deal …

Impact on SUNPHARMA: The acquisition is likely to boost Sun Pharma's stock price, with potential …

Sun Pharmaceutical Industries is acquiring Organon & Co for $11.75 billion, marking a significant expansion … High (80%)

View full analysis →

CNBC 80% confidence